Abstract
Recently, we have shown that radiotherapy (RT) combined with L19-IL2 can induce a long-lasting antitumor effect, dependent on ED-B expression and infiltration of cytotoxic T cells. These findings will be translated to a Phase I clinical study (NCT02086721) in patients with oligometastatic solid tumors. See this link for the animation: http://youtu.be/xHbwQuCTkRc.
Original language | English |
---|---|
Article number | e1021541 |
Journal | OncoImmunology |
Volume | 4 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2015 |